Nucleic acid and amino acid sequences relating to
The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
1. A method of making a S. pneumoniae polypeptide, comprising the step of culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector comprises a nucleic acid sequence that encodes a polypeptide having the amino acid sequence as set forth in SEQ ID NO: 5326.
2. The method of claim 1 , further including the step of isolating the polypeptide from the host cell.
3. The method of claim 1 , wherein the host cell is a prokaryotic host cell.
4. The method of claim 3 , wherein the prokaryotic host cell is selected from the group consisting of E. coli, B. subtilis and S. aureus.
5. The method of claim 4 , wherein the prokaryotic host cell is E. coli.
6. The method of claim 1 , wherein the host cell is a eukaryotic host cell.
7. The method of claim 6 , wherein the eukaryotic host cell is selected from the group consisting of an insect cell, a yeast cell and a mammalian cell.
8. The method of claim 7 , wherein the eukaryotic host cell is an insect cell.
9. The method of claim 7 , wherein the mammalian cell is a Chinese hamster ovary cell.
10. The method of claim 1 , wherein the polypeptide elicits an immune response.
11. The method of claim 10 , wherein the immune response is an immune response against S. pneumoniae infection.
12. A method of making a S. pneumoniae polypeptide, comprising the step of culturing a host cell that includes a recombinant expression vector, wherein the recombinant expression vector comprises a nucleic acid sequence that encodes a polypeptide having at least 80% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 5326.
13. The method of claim 12 , further including the step of isolating the polypeptide from the host cell.
14. The method of claim 12 , wherein the nucleic acid sequence encodes a polypeptide having at least 90% identity to SEQ ID NO: 5326.
15. The method of claim 12 , wherein the nucleic acid sequence encodes a polypeptide having at least 95% identity to SEQ ID NO: 5326.
16. The method of claim 12 , wherein the nucleic acid sequence encodes a polypeptide having at least 98% identity to SEQ ID NO: 5326.
17. The method of claim 12 , wherein the nucleic acid sequence encodes a polypeptide having at least 99% identity to SEQ ID NO: 5326.
18. The method of claim 12 , wherein the polypeptide elicits an immune response.
19. The method of claim 12 , wherein the immune response is an immune response against S. pneumoniae infection.
20. The method of claim 8 , wherein the recombinant expression vector is a baculovirus expression vector.
21. The method of claim 1 , wherein the polypeptide is a surface protein.
22. The method of claim 12 , wherein the polypeptide is a surface protein.